Short-term outcomes of heart transplant patients bridged with Impella 5.5 ventricular assist device.
Osama HaddadBasar SareyyupogluRohan M GoswamiMacit BitargilParag C PatelSamuel JacobMagdy M El-Sayed AhmedJuan Carlos Leoni MorenoDaniel S YipKevin LandolfoSi M PhamPublished in: ESC heart failure (2023)
Impella 5.5 temporary left ventricular assist device optimizes care of heart transplant recipients providing superior haemodynamic support, mobility, improved renal function, pulmonary haemodynamics, and right ventricular function. Utilizing Impella 5.5 as a direct bridging strategy to heart transplantation resulted in excellent outcomes.
Keyphrases
- left ventricular assist device
- heart failure
- end stage renal disease
- healthcare
- extracorporeal membrane oxygenation
- chronic kidney disease
- newly diagnosed
- ejection fraction
- prognostic factors
- palliative care
- pulmonary hypertension
- left ventricular
- quality improvement
- pain management
- metabolic syndrome
- adipose tissue
- health insurance